
CAS 740816-86-8
:Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-hydroxy-9-méthyl-1-oxo-9,13-époxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-méthyl-
- O-Desmethyl PKC412
- O-Desmethyl Midostaurin (CGP62221)
- Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-hydroxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-
- Midostaurin Impurity 2 (O-Desmethyl Midostaurin)
- CGP62221
- O-Desmethyl Midostaurin
O-Desmethyl Midostaurin (CGP62221)
CAS :Formule :C34H28N4O4Couleur et forme :Pale Yellow SolidMasse moléculaire :556.62O-Desmethyl Midostaurin
CAS :Stability Hygroscopic
Applications O-Desmethyl Midostaurin is a metabolite of Midostaurin (M343760), a compound shown to possess antiproliferative characteristics via inhibition of protein kinase C, kinase insert domain receptor, and c-kit.
References Tahtouh, T., et al.: J. Med. Chem., 55, 9312 (2012); Pedeboscq, S., et al.: PLoS. One., 7, 36811 (2012);Formule :C34H28N4O4Couleur et forme :NeatMasse moléculaire :556.61O-Desmethyl Midostaurin-13C6
CAS :Produit contrôléApplications O-Desmethyl Midostaurin-13C6 is the labelled analogue of O-Desmethyl Midostaurin (D291400), a metabolite of Midostaurin (M343760), a compound shown to possess antiproliferative characteristics via inhibition of protein kinase C, kinase insert domain receptor, and c-kit.
References Tahtouh, T., et al.: J. Med. Chem., 55, 9312 (2012); Pedeboscq, S., et al.: PLoS. One., 7, 36811 (2012);Formule :C2813C6H28N4O4Couleur et forme :NeatMasse moléculaire :562.57O-Desmethyl Midostaurin-d5
CAS :Produit contrôléApplications O-Desmethyl Midostaurin-d5 is a deuterium labelled derivative of O-Desmethyl Midostaurin (D291400(M)). O-Desmethyl Midostaurin is a metabolite of Midostaurin (M343760), a compound shown to possess antiproliferative characteristics via inhibition of protein kinase C, kinase insert domain receptor, and c-kit. O-Desmethyl Midostaurini is also an active metabolite involved in cytochrome P450 liver enzyme metabolism.
References Tahtouh, T., et al.: J. Med. Chem., 55, 9312 (2012); Pedeboscq, S., et al.: PLoS. One., 7, 36811 (2012); Levis, M., et al.: NLM, 108, 3477 (2006)Formule :C34D5H23N4O4Couleur et forme :NeatMasse moléculaire :561.641o-Desmethyl midostaurin-13C6
CAS :Midostaurin is a therapeutic agent for the treatment of chronic myeloid leukemia. It belongs to the family of inhibitors that bind to ion channels and inhibit their activity. The drug has been shown to be an inhibitor of potassium channels, calcium channels, and sodium channels. Midostaurin has been found to bind to the receptor activator of nuclear factor kappa-B ligand (RANKL) on cells in culture, which may contribute to its anti-inflammatory effects.
Formule :C34H28N4O4Degré de pureté :Min. 95%Masse moléculaire :556.6 g/molO-Desmethyl Midostaurin
CAS :O-Desmethyl Midostaurin is the active Midostaurin metabolite via cytochrome P450 liver enzyme metabolism.Formule :C34H28N4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :556.61




